Know Cancer

forgot password

Sexual Functioning After Primary Treatment of Ovarian Cancer

18 Years
Open (Enrolling)
Ovarian Cancer, Sexual Dysfunction

Thank you

Trial Information

Sexual Functioning After Primary Treatment of Ovarian Cancer

Inclusion Criteria:

- Women with any stage of invasive epithelial ovarian cancer who have completed
frontline therapy within the past 6 months

- Women must have no clinical evidence of disease

- At least 18 years of age

- English speaking

- Able to participate in the informed consent process

- Women who present to Sexual Health Clinic for the first time and meet all other
eligibility criteria are eligible. Their FSFI scores will be used to determine the
primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the
FSFI, they may still elect to be followed at the SHC.

Exclusion Criteria:

- Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment

- Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT,
PET scan etc) or physical examination

- Women with borderline (low malignant potential) ovarian cancers

- Women who are already in active evaluation and/or follow-up at the Sexual Health

- Women with a history of prior whole pelvic radiation

Type of Study:


Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease.

Outcome Time Frame:

conclusion of study

Safety Issue:


Principal Investigator

Elizabeth Jewell, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

November 2004

Completion Date:

November 2013

Related Keywords:

  • Ovarian Cancer
  • Sexual Dysfunction
  • sexual dysfunction
  • Ovarian Neoplasms
  • Sexual Dysfunctions, Psychological



Memorial Sloan Kettering Cancer Center New York, New York  10021